Divi's Laboratories announced a robust financial performance for the March quarter of FY25, with a 25.6% YoY surge in standalone net profit, reaching Rs 667 crore. Revenue from operations also climbed by 12.26% to Rs 2,536 crore. The company's board declared a dividend of Rs 30 per share and (...)
Site référencé: The Economic Times
The Economic Times
Emkay picks JK Cement, Motilal Oswal, 2 more small & midcap stocks. 4 reasons why
22/05/2025
Kumar Mangalam Birla's Grasim gets cheapest rupee bond deal in 5 years
22/05/2025
Markets move fast, but compounding moves faster : A Balasubramanian on why the next decade will be transformational
22/05/2025
Gold prices rise for 4 consecutive sessions, gain by Rs 3,800. Check price prediction
22/05/2025
Tyre stocks are a safe bet amid auto sector uncertainty and falling rubber prices : Anshul Saigal
22/05/2025
Fund Manager Talk | Defence stocks rally shows FOMO taking over rationality, says Kotak's Atul Bhole
22/05/2025
